【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Ischemia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Ischemia 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Ischemia Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AnGes MG, Inc. 35
Clinical Trial Overview of AnGes MG, Inc. 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Lacer, S.A. 37
Clinical Trial Overview of Lacer, S.A. 37
Sangart, Inc. 38
Clinical Trial Overview of Sangart, Inc. 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
TCA Cellular Therapy, LLC 40
Clinical Trial Overview of TCA Cellular Therapy, LLC 40
Stempeutics Research Private Limited 41
Clinical Trial Overview of Stempeutics Research Private Limited 41
Medicure Inc. 42
Clinical Trial Overview of Medicure Inc. 42
ReNeuron Group plc 43
Clinical Trial Overview of ReNeuron Group plc 43
Pluristem Therapeutics Inc. 44
Clinical Trial Overview of Pluristem Therapeutics Inc. 44
Medistem, Inc. 45
Clinical Trial Overview of Medistem, Inc. 45
ViroMed Co., Ltd. 46
Clinical Trial Overview of ViroMed Co., Ltd. 46
United Therapeutics Corporation 47
Clinical Trial Overview of United Therapeutics Corporation 47
Cytori Therapeutics, Inc. 48
Clinical Trial Overview of Cytori Therapeutics, Inc. 48
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
medac GmbH 50
Clinical Trial Overview of medac GmbH 50
Gilead Sciences, Inc. 51
Clinical Trial Overview of Gilead Sciences, Inc. 51
AstraZeneca PLC 52
Clinical Trial Overview of AstraZeneca PLC 52
Forest Laboratories, Inc. 53
Clinical Trial Overview of Forest Laboratories, Inc. 53
Mitsubishi Tanabe Pharma Corporation 54
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 54
Clinical Trial Overview of Top Institutes / Government 55
National Heart, Lung, and Blood Institute 55
Clinical Trial Overview of National Heart, Lung, and Blood Institute 55
Radboud University 59
Clinical Trial Overview of Radboud University 59
Northwestern University 60
Clinical Trial Overview of Northwestern University 60
Medical University of Vienna 61
Clinical Trial Overview of Medical University of Vienna 61
Leiden University Medical Center 62
Clinical Trial Overview of Leiden University Medical Center 62
University Hospital Freiburg 63
Clinical Trial Overview of University Hospital Freiburg 63
Imperial College London 64
Clinical Trial Overview of Imperial College London 64
Duke University 65
Clinical Trial Overview of Duke University 65
U.S. Department of Veterans Affairs 66
Clinical Trial Overview of U.S. Department of Veterans Affairs 66
Seoul National University Hospital 67
Clinical Trial Overview of Seoul National University Hospital 67
Asan Medical Center 68
Clinical Trial Overview of Asan Medical Center 68
Yale University 69
Clinical Trial Overview of Yale University 69
Erasmus MC 70
Clinical Trial Overview of Erasmus MC 70
Charite – Universitatsmedizin Berlin 71
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 71
Kyushu University 72
Clinical Trial Overview of Kyushu University 72
Academic Medical Centre 73
Clinical Trial Overview of Academic Medical Centre 73
Fundacion Progreso y Salud 74
Clinical Trial Overview of Fundacion Progreso y Salud 74
Maastricht University Medical Center 75
Clinical Trial Overview of Maastricht University Medical Center 75
Assistance Publique – Hopitaux de Paris 76
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 76
University of Florida 77
Clinical Trial Overview of University of Florida 77
Five Key Clinical Profiles 78
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112
【レポート販売概要】
■ タイトル：Ischemia：グローバル臨床試験レビューH1, 2013■ 英文：Ischemia Global Clinical Trials Review, H1, 2013
■ 発行日：2013年6月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161266
■ 調査対象地域：グローバル
- 有効栄養補助食品の世界市場展望2017-20276According to Stratistics MRC, the Global Active Nutraceutical Ingredients Market is to grow at a CAGR of 8.3% during the forecast period. Some of the key factors fueling the market are increasing health awareness among people and growing demand for healthy food. However, High costs involved in the R&D activities along with high price for fortified and enriched products hampers the market growth of …
- 風力タービンOEMメーカーの戦略：コストと収益性Cost-Cutting Measures in 2013 - Key Strategies to Improve Original Equipment Manufacturer Profitability Summary Wind turbine manufacturers faced cut-throat competition in 2012 and 2013. Higher variable costs and increasing raw material costs adversely affected the financial statements of most Original Equipment Manufacturers (OEM). Most OEMs employed drastic cost-cutting measures in an effort to i …
- 医療用シールの世界市場予測（～2023年）“The growth in the medical equipment application is expected to drive the medical processing seals market.”The medical processing seals market size is estimated to be USD 1.4 billion in 2018 and is projected to reach USD 1.8 billion by 2023, at a CAGR of 5.0%. Majority of medical processing seals are consumed in the medical equipment industry. Capacity expansion in this industry will drive the dem …
- 核酸増幅試験の世界市場分析：用途別（感染症、がん、個別化医療、遺伝）、方法別（標的増幅、プローブ増幅、シグナル増幅）、セグメント予測、2014-2025The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including …
- ターミナルオートメーションの世界市場2016-2020About Terminal Automation A bulk loading terminal or large depot stores products from industries, such as oil and gas, and chemicals and petrochemicals, which are received through cross-country pipelines, railways, ships, and trucks and stored in tank farms. These products are distributed through trucks, railways, barges, ships, and pipelines. A supervisory and regulatory software system enables t …
- PPM及びITガバナンスの世界市場2016-2020About PPM and IT Governance PPM and IT governance solutions are helping organizations manage their projects with the help of advanced IT solutions, such as predictive analytics and augmented reality. Earlier, organizations were implementing separate solutions for IT governance and analytics for PPM. Vendors in the market have recognized the problems encountered by their clients while managing proj …
- 世界の睡眠時無呼吸症候群治療市場動向（～2020）Sleep apnea is a common disorder that occurs when a person’s breathing is interrupted during sleep. Sleep apnea is a chronic condition and often largely goes undiagnosed. Sleep apnea can be further differentiated into three types: obstructive sleep apnea, central sleep apnea, and complex/mixed sleep apnea. Obstructive sleep apnea occurs when the muscles relax during sleep, causing soft tissue in t …
- 構造用接着剤の世界市場予測（～2024年）The structural adhesives market is projected to register a CAGR of 6.8%, in terms of value, between 2019 and 2024The structural adhesives market is expected to grow from USD 14.0 billion in 2019 to USD 19.4 billion by 2024, at a CAGR of 6.9%, between 2019 and 2024. APAC is the largest consumer of structural adhesives. Low-cost of manufacturing in APAC countries and high demand for structural adhes …
- PegIntron (Hepatitis C Virus)：市場予測と分析（～2022）PegIntron (Hepatitis C Virus) - Forecast and Market Analysis to 2022 Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the market is driven by therapeutics. Curr …
- アセチルアセトン鉄の世界市場2015Ferric acetylacetonate (CAS 14024-18-1) Market Research Report 2015 aims at providing comprehensive data on Ferric acetylacetonate market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Ferric acetylacetonate description, covers its application areas, manufacturing methods, patterns. It captures Ferric acetylacetonate market trends, pays close attentio …
- 自動車用流体フィルタの世界市場：オイルフィルタ、燃料フィルタThe global fluid filter market attained a market size, in terms of value, of $823.1 million in 2014, and is expected to reach $1,463.7 million by 2019, at a CAGR of 12.2 % from 2014 to 2019. Asia-Pacific is expected to hold a market share, in terms of volume, of 55.2% in the fluid market by 2019, growing at a CAGR of 8.2% from 2014 to 2019. The fluid filter market is segregated on the basis of reg …
- 1,3-ブタンジオールの世界市場20151,3-Butanediol (CAS 107-88-0) Market Research Report 2015 aims at providing comprehensive data on 1,3-Butanediol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes 1,3-Butanediol description, covers its application areas, manufacturing methods, patterns. It captures 1,3-Butanediol market trends, pays close attention to 1,3-Butanediol manufacturers …
- 外傷と四肢の世界市場分析：タイプ別（外部固定、内部固定[プレートおよびネジ、ロッドおよびピン、骨移植片]、頭蓋内装置[内頚部装置、外科頭蓋装置]、長骨刺激、他の外傷装置）、セグメント予測The global trauma and extremities market was valued at USD 8.0 billion in 2015 and is expected to reach a value of USD 15.9 billion by 2024. The expansion is attributed to the increasing geriatric population base along with the growing incidence rate of target diseases such as osteoporosis. Introduction of new technologies in terms of material, technique, and the non-invasive nature of the employe …
- B型肝炎ウイルス（HPV）治療市場：日本の治療薬市場Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people wor …
- ウェアラブル・スキャナーの世界市場2016-2020About the Wearable Scanner Market Wearable scanners are increasingly adopted in many industries, leading to higher revenues for the market. They are widely used in applications related to the healthcare, transportation and logistics, manufacturing, hospitality and entertainment, retail, and services industries because of their ability to capture data accurately and at a high speed. At present, 2D …
